Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-31

FDA Approved: DECITABINE — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approves an Original Application for decitabine as a generic product (ANDA204607) by Mylan Institutional LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Decitabine (Decitabine)

Snippet

ORIG AP for DECITABINE (DECITABINE)